Biosimilars Approved in Europe

Biosimilars Approved in Europe Photo

Biosimilars have been broadly and securely utilized as a part of Europe since 2006. In 2004, the European Commission (EC) passed enactment making a Biosimilars endorsement pathway (Directive 2001/83/EC Directive 2004/27/EC). In 2005 and 2006, the European Medicines Agency (EMA) discharged its first arrangement of biosimilar rules, and in 2006, endorsed its first biosimilar. To date, there have been 14 Biosimilars approved, with biosimilar monoclonal antibodies expected soon. In spite of a thorough observing, following, and following framework, Europe has distinguished no security issues with Biosimilars.

Are you interested in

Mail us at

Programs & Speaking Engagement
biosimilars@alliedmeetings.com
Sponsorship
john.wilson@alliedmeetings.com
Group Discounts and Delegates
biosimilars@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy

By registering for the conference you grant permission to Allied Academies to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute,broadcast,edit and/or digitize the resulting images and materials in publications, advertising materials,or in any other form worldwide without compensation. Taking of photographs and/or video taping during any session is prohibited. Contact us for any queries
Copyright © 2018-2019 Allied Academies, All Rights Reserved.